Optically Improved Mitochondrial Function Redeems Aged Human Visual Decline.
Level 4 - case-series / case-control
Uncontrolled before-after interventional study in humans without reported randomization or sham control group in the abstract.
PubMed 32596723 · doi:10.1093/gerona/glaa155
What was done
Investigators evaluated the effects of 670-nm red light on psychophysically measured rod and cone photoreceptor performance in human participants aged 28 to 72 years. The abstract does not state the sample size, light delivery protocol (irradiance, duration, frequency), or whether a sham comparator was used.
What was found
Rod and cone performance declined after approximately 40 years of age. Application of 670-nm light produced no measurable impact in younger participants. In those aged approximately 40 years and older, 670-nm light led to statistically significant improvements in color contrast sensitivity along the blue visual axis (tritan) and in rod visual thresholds. Improvements along the red visual axis (protan) did not reach statistical significance. The abstract reports no numerical values, effect sizes, or exact p-values.
Why it matters
This study provides proof-of-concept in humans that targeting retinal mitochondrial function with 670-nm light may temporarily ameliorate age-related declines in scotopic and tritan color vision.
Limits
The abstract omits critical trial details, including participant count, inclusion/exclusion criteria, exact light dosage, duration of observed improvements, and quantitative statistical metrics. The lack of a described randomized sham control group precludes ruling out placebo effects or test-retest learning in psychophysical testing.